表紙:末梢血管デバイスの世界市場:2021年~2028年の予測
市場調査レポート
商品コード
991397

末梢血管デバイスの世界市場:2021年~2028年の予測

Global Peripheral Vascular Devices Market Forecast 2021-2028

出版日: | 発行: Inkwood Research | ページ情報: 英文 203 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.08円
末梢血管デバイスの世界市場:2021年~2028年の予測
出版日: 2021年03月01日
発行: Inkwood Research
ページ情報: 英文 203 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の末梢血管デバイスの市場規模は、2021年から2028年の予測期間中に、11.1%のCAGRで成長する見通しです。同市場の成長要因には、末梢動脈疾患の低侵襲手術に対する需要の急増、末梢動脈疾患の発生率の上昇、技術の進歩、高齢人口の増加、ライフスタイルの変化などが挙げられます。

当レポートは、世界の末梢血管デバイス市場について調査しており、市場規模や推計、成長および抑制要因、デバイスタイプ・地域別の市場分析、COVID-19の影響、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査範囲と調査手法

  • 調査目的
  • 調査範囲
  • 調査手法
  • 前提条件と制限

第2章 エグゼクティブサマリー

  • 市場規模・推計
  • 市場概要

第3章 市場力学

  • 主な成長要因
    • 末梢動脈疾患の最小限の侵襲的処置に対する需要の急増
    • 末梢動脈疾患の発生率の増加
    • 高齢人口とライフスタイルの変化の増加
    • 技術の進歩
  • 主な抑制要因
    • 厳格な規制
    • 末梢血管装置の適切な償還方針の欠如
    • 激しい競争

第4章 主な分析

  • 市場に対するCOVID-19の影響
  • 主な投資の洞察
  • ポーターのファイブフォース分析
  • 市場機会マトリックス
  • ベンダー情勢

第5章 市場分析:デバイスタイプ別

  • 末梢血管ステント
    • 自己拡張型末梢血管ステント
    • バルーン拡張型末梢血管ステント
    • 薬剤溶出型末梢血管用ステント
    • カバードステント
  • PTAバルーンカテーテル
    • 標準のPTAバルーンカテーテル
    • 高圧PTAバルーンカテーテル
    • 大型PTAバルーンカテーテル
    • 小型PTAバルーンカテーテル
    • 特殊PTAバルーンカテーテル
    • 薬物被覆PTAバルーンカテーテル
  • PTAガイドワイヤー
  • 粥腫切除装置
  • 塞栓保護装置
  • 下大静脈フィルター
  • その他

第6章 市場分析:地域別

  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第7章 競合情勢

  • 主な戦略的開発
    • 合併と買収
    • 製品の発売と開発
    • 提携、契約および協業
    • 事業拡大
  • 企業プロファイル
    • ABBOTT LABORATORIES
    • BOSTON SCIENTIFIC CORPORATION
    • BECTON, DICKINSON AND COMPANY
    • COOK GROUP
    • CARDINAL HEALTH INC (CORDIS)
    • EDWARDS LIFESCIENCES CORPORATION
    • MEDTRONIC PLC
    • KONINKLIJKE PHILIPS NV (VOLCANO)
    • ANGIOSCORE INC (SPECTRANETICS CORPORATION)
    • TELEFLEX MEDICAL
    • TERUMO INTERVENTIONAL SYSTEMS INC
    • ENDOLOGIX
図表

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - PERIPHERAL VASCULAR DEVICES
  • TABLE 2: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY DEVICE TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 3: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY DEVICE TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 4: GLOBAL PERIPHERAL VASCULAR STENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 5: GLOBAL PERIPHERAL VASCULAR STENTS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 6: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY PERIPHERAL VASCULAR STENTS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 7: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY PERIPHERAL VASCULAR STENTS, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 8: GLOBAL SELF EXPANDING PERIPHERAL VASCULAR STENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 9: GLOBAL SELF EXPANDING PERIPHERAL VASCULAR STENTS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 10: GLOBAL BALLOON EXPANDING PERIPHERAL VASCULAR STENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 11: GLOBAL BALLOON EXPANDING PERIPHERAL VASCULAR STENTS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 12: GLOBAL DRUG ELUTING PERIPHERAL VASCULAR STENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 13: GLOBAL DRUG ELUTING PERIPHERAL VASCULAR STENTS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 14: GLOBAL COVERED STENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 15: GLOBAL COVERED STENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 16: GLOBAL PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 17: GLOBAL PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 18: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 19: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 20: GLOBAL STANDARD PTA BALLOON CATHETERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 21: GLOBAL STANDARD PTA BALLOON CATHETERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 22: GLOBAL HIGH-PRESSURE PTA BALLOON CATHETER MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 23: GLOBAL HIGH-PRESSURE PTA BALLOON CATHETER MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 24: GLOBAL LARGE PTA BALLOON CATHETER MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 25: GLOBAL LARGE PTA BALLOON CATHETER MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 26: GLOBAL SMALL PTA BALLOON CATHETER MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 27: GLOBAL SMALL PTA BALLOON CATHETER MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 28: GLOBAL SPECIALTY PTA BALLOON CATHETER MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 29: GLOBAL SPECIALTY PTA BALLOON CATHETER MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 30: GLOBAL DRUG COATED PTA BALLOON CATHETER MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 31: GLOBAL DRUG COATED PTA BALLOON CATHETER MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 32: GLOBAL PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) GUIDEWIRES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 33: GLOBAL PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) GUIDEWIRES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 34: GLOBAL ATHERECTOMY DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 35: GLOBAL ATHERECTOMY DEVICES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 36: GLOBAL EMBOLIC PROTECTION DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 37: GLOBAL EMBOLIC PROTECTION DEVICES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 38: GLOBAL INFERIOR VENA CAVA FILTERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 39: GLOBAL INFERIOR VENA CAVA FILTERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 40: GLOBAL OTHER DEVICE TYPES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 41: GLOBAL OTHER DEVICE TYPES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 42: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 43: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY GEOGRAPHY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 44: NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 45: NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 46: LEADING PLAYERS OPERATING IN NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET
  • TABLE 47: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 48: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 49: LEADING PLAYERS OPERATING IN EUROPE PERIPHERAL VASCULAR DEVICES MARKET
  • TABLE 50: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 51: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 52: LEADING PLAYERS OPERATING IN ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET
  • TABLE 53: REST OF WORLD PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 54: REST OF WORLD PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 55: LEADING PLAYERS OPERATING IN REST OF THE WORLD PERIPHERAL VASCULAR DEVICES MARKET
  • TABLE 56: LIST OF MERGERS & ACQUISITIONS
  • TABLE 57: LIST OF PRODUCTS LAUNCHES & DEVELOPMENTS
  • TABLE 58: LIST OF PARTNERSHIPS & AGREEMENTS
  • TABLE 59: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

  • FIGURE 1: KEY INVESTMENT INSIGHTS
  • FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, GROWTH POTENTIAL, BY DEVICE TYPE, IN 2020
  • FIGURE 6: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)
  • FIGURE 7: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, GROWTH POTENTIAL, BY PERIPHERAL VASCULAR STENTS, IN 2020
  • FIGURE 8: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY SELF EXPANDING PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)
  • FIGURE 9: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY BALLOON EXPANDING PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)
  • FIGURE 10: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY DRUG ELUTING PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)
  • FIGURE 11: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY COVERED STENT, 2021-2026 (IN $ MILLION)
  • FIGURE 12: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS, 2021-2028 (IN $ MILLION)
  • FIGURE 13: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, GROWTH POTENTIAL, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS, IN 2020
  • FIGURE 14: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY STANDARD PTA BALLOON CATHETERS, 2021-2028 (IN $ MILLION)
  • FIGURE 15: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY HIGH-PRESSURE PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)
  • FIGURE 16: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY LARGE PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)
  • FIGURE 17: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY SMALL PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)
  • FIGURE 18: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY SPECIALTY PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)
  • FIGURE 19: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY DRUG COATED PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)
  • FIGURE 20: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) GUIDEWIRES, 2021-2028 (IN $ MILLION)
  • FIGURE 21: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY ATHERECTOMY DEVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 22: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION DEVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 23: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY INFERIOR VENA CAVA FILTERS, 2021-2028 (IN $ MILLION)
  • FIGURE 24: GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, BY OTHER DEVICE TYPES, 2021-2028 (IN $ MILLION)
  • FIGURE 25: NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 26: UNITED STATES PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 27: CANADA PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 28: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 29: UNITED KINGDOM PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 30: GERMANY PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 31: FRANCE PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 32: ITALY PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 33: RUSSIA PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 34: BELGIUM PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 35: POLAND PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 36: REST OF EUROPE PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 37: ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 38: CHINA PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 39: JAPAN PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 40: INDIA PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 41: SOUTH KOREA PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 42: INDONESIA PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 43: THAILAND PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 44: VIETNAM PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 45: AUSTRALIA & NEW ZEALAND PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 46: REST OF ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION
  • FIGURE 47: REST OF WORLD PERIPHERAL VASCULAR DEVICES MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 48: LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 49: MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
目次
Product Code: 36160

KEY FINDINGS

The global peripheral vascular devices market is projected to register a CAGR of 11.10%, during the forecast period of 2021 to 2028. The market growth is accredited to factors, such as, the surging demand for minimally invasive procedures for peripheral arterial disease, the rising incidence of peripheral arterial disease, technological advancements, the increasing geriatric population, and lifestyle changes.

MARKET INSIGHTS

Peripheral arterial disease entails the build-up of plaque in arteries carrying blood from the heart to the arms, legs, and other limbs. The condition also increases the risk of several other peripheral ailments, including, coronary heart disease, heart attack, ischemic attacks, and stroke.

The leading cause of peripheral arterial disease entails smoking, the increased amount of cholesterol and fat in the blood, elevated amounts of blood sugar due to diabetes and insulin resistance, high blood pressure, and diabetes. Moreover, lifestyle changes have also been observed across the global population, attributed to the absence of a proper work-life balance. People in developing economies are also succumbing to additions, such as, alcohol, smoking, and drug abuse, which significantly impact their health. Moreover, disorders associated with the cardiovascular system emerge due to such habits, as well.

REGIONAL INSIGHTS

The global peripheral vascular devices market growth is assessed by evaluating North America, the Asia-Pacific, Europe, and the rest of the world. North America held the highest market share in 2020, owing to factors such as, the augmenting geriatric population, and continually changing lifestyle habits like excessive alcohol consumption, unhealthy diet, obesity, smoking, and lack of physical activity, among others.

COMPETITIVE INSIGHTS

The global market observes high competition among key players. Moreover, the companies undergo mergers and acquisitions in order to extend the present product portfolio. In addition, product developments, as well as the extension of applications for approved products, are among the key strategies adopted by players, to maintain a competitive edge within the global peripheral vascular devices market.

Some of the leading companies operating in the market are, Edward Lifesciences Corporation, Abbott Laboratories, Boston Scientific Corporation, Edward Lifesciences Corporation, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. SURGE IN DEMAND FOR MINIMALLY-INVASIVE PROCEDURES FOR PERIPHERAL ARTERIAL DISEASE
    • 3.1.2. GROWING INCIDENCE OF PERIPHERAL ARTERIAL DISEASE
    • 3.1.3. INCREASING AGING POPULATION AND LIFESTYLE CHANGES
    • 3.1.4. TECHNOLOGICAL ADVANCEMENTS
  • 3.2. KEY RESTRAINTS
    • 3.2.1. STRINGENT REGULATIONS
    • 3.2.2. LACK OF PROPER REIMBURSEMENT POLICIES FOR PERIPHERAL VASCULAR DEVICES
    • 3.2.3. HIGH COMPETITION
  • 3.3. KEY RESTRAINTS
    • 3.3.1. STRINGENT REGULATIONS
    • 3.3.2. LACK OF PROPER REIMBURSEMENT POLICIES FOR PERIPHERAL VASCULAR DEVICES
    • 3.3.3. HIGH COMPETITION

4. KEY ANALYTICS

  • 4.1. IMPACT OF COVID-19 ON PERIPHERAL VASCULAR DEVICES MARKET
  • 4.2. KEY INVESTMENT INSIGHTS
  • 4.3. PORTER'S FIVE FORCES ANALYSIS
    • 4.3.1. BUYERS POWER
    • 4.3.2. SUPPLIERS POWER
    • 4.3.3. SUBSTITUTIONS
    • 4.3.4. NEW ENTRANTS
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. OPPORTUNITY MATRIX
  • 4.5. VENDOR LANDSCAPE

5. MARKET BY DEVICE TYPE

  • 5.1. PERIPHERAL VASCULAR STENTS
    • 5.1.1. SELF EXPANDING PERIPHERAL VASCULAR STENTS
    • 5.1.2. BALLOON EXPANDING PERIPHERAL VASCULAR STENTS
    • 5.1.3. DRUG ELUTING PERIPHERAL VASCULAR STENTS
    • 5.1.4. COVERED STENT
  • 5.2. PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS
    • 5.2.1. STANDARD PTA BALLOON CATHETERS
    • 5.2.2. HIGH-PRESSURE PTA BALLOON CATHETER
    • 5.2.3. LARGE PTA BALLOON CATHETER
    • 5.2.4. SMALL PTA BALLOON CATHETER
    • 5.2.5. SPECIALTY PTA BALLOON CATHETER
    • 5.2.6. DRUG COATED PTA BALLOON CATHETER
  • 5.3. PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) GUIDEWIRES
  • 5.4. ATHERECTOMY DEVICES
  • 5.5. EMBOLIC PROTECTION DEVICES
  • 5.6. INFERIOR VENA CAVA FILTERS
  • 5.7. OTHER DEVICE TYPES

6. GEOGRAPHICAL ANALYSIS

  • 6.1. NORTH AMERICA
    • 6.1.1. KEY GROWTH ENABLERS
    • 6.1.2. KEY CHALLENGES
    • 6.1.3. KEY PLAYERS
    • 6.1.4. COUNTRY ANALYSIS
      • 6.1.4.1. UNITED STATES
      • 6.1.4.2. CANADA
  • 6.2. EUROPE
    • 6.2.1. KEY GROWTH ENABLERS
    • 6.2.2. KEY CHALLENGES
    • 6.2.3. KEY PLAYERS
    • 6.2.4. COUNTRY ANALYSIS
      • 6.2.4.1. UNITED KINGDOM
      • 6.2.4.2. GERMANY
      • 6.2.4.3. FRANCE
      • 6.2.4.4. ITALY
      • 6.2.4.5. RUSSIA
      • 6.2.4.6. BELGIUM
      • 6.2.4.7. POLAND
      • 6.2.4.8. REST OF EUROPE
  • 6.3. ASIA-PACIFIC
    • 6.3.1. KEY GROWTH ENABLERS
    • 6.3.2. KEY CHALLENGES
    • 6.3.3. KEY PLAYERS
    • 6.3.4. COUNTRY ANALYSIS
      • 6.3.4.1. CHINA
      • 6.3.4.2. JAPAN
      • 6.3.4.3. INDIA
      • 6.3.4.4. SOUTH KOREA
      • 6.3.4.5. INDONESIA
      • 6.3.4.6. THAILAND
      • 6.3.4.7. VIETNAM
      • 6.3.4.8. AUSTRALIA & NEW ZEALAND
      • 6.3.4.9. REST OF ASIA-PACIFIC
  • 6.4. REST OF WORLD
    • 6.4.1. KEY GROWTH ENABLERS
    • 6.4.2. KEY CHALLENGES
    • 6.4.3. KEY PLAYERS
    • 6.4.4. REGIONAL ANALYSIS
      • 6.4.4.1. LATIN AMERICA
      • 6.4.4.2. MIDDLE EAST & AFRICA

7. COMPETITIVE LANDSCAPE

  • 7.1. KEY STRATEGIC DEVELOPMENTS
    • 7.1.1. MERGERS & ACQUISITIONS
    • 7.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 7.1.3. PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS
    • 7.1.4. BUSINESS EXPANSIONS
  • 7.2. COMPANY PROFILES
    • 7.2.1. ABBOTT LABORATORIES
    • 7.2.2. BOSTON SCIENTIFIC CORPORATION
    • 7.2.3. BECTON, DICKINSON AND COMPANY
    • 7.2.4. COOK GROUP
    • 7.2.5. CARDINAL HEALTH INC (CORDIS)
    • 7.2.6. EDWARDS LIFESCIENCES CORPORATION
    • 7.2.7. MEDTRONIC PLC
    • 7.2.8. KONINKLIJKE PHILIPS NV (VOLCANO)
    • 7.2.9. ANGIOSCORE INC (SPECTRANETICS CORPORATION)
    • 7.2.10. TELEFLEX MEDICAL
    • 7.2.11. TERUMO INTERVENTIONAL SYSTEMS INC
    • 7.2.12. ENDOLOGIX